EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

The Role of Cutaneous B‐Cells in Hidradenitis Suppurativa: From Preclinical Evidence to Novel Targeted Therapies

Maurizio Romagnuolo iD, Laura Calabrese, Martina D'Onghia, Vittoria Cioppa iD, Pietro Rubegni, Angelo Valerio Marzano iD, Chiara Moltrasio iD

Experimental Dermatology · 2025-09 · 34 (9)

DOI: 10.1111/exd.70163 ↗

At a glance

Übersichtsarbeit in Experimental Dermatology, published online on 2025-09-02. Written by Maurizio Romagnuolo and 6 co-authors. Institution: Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Major MEDLINE topics: Hidradenitis Suppurativa, B-Lymphocytes, Skin. Cited 7 times so far (Crossref); 71 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Hidradenitis Suppurativa (HS) is a chronic autoinflammatory skin disease of the terminal hair follicle, whose pathogenesis is complex and multifactorial. Alongside a predisposing genetic background, environmental/epigenetic factors, alterations in the skin microbiome, and dysregulation of both innate and adaptive immune responses contribute to the persistent inflammatory network. Despite advancing knowledge, the exact molecular and cellular mechanisms underlying HS have yet to be untangled. Moreover, the lack of experimental disease models that closely mimic disease phenotypes or pathophysiological processes has hindered the development of effective therapeutic strategies. Recent advances in immunology highlighted the important role of B cells in HS pathogenesis, not only in the chronic but also in the early stages of the disease, implying great potential for the development of novel therapeutic targets. This study gathers the preclinical and clinical scientific evidence that supports the role of cutaneous B‐cells in HS pathogenesis and the therapeutic potential of their targeting.

Subjects

MeSH terms (MEDLINE)

Hidradenitis SuppurativaB-LymphocytesSkinHumansAnimalsMolecular Targeted Therapy

Author keywords

BTK inhibitorsOX40Lcutaneous B‐cellshidradenitis suppurativarituximab

Authors and institutions

  • Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Dermatology Unit, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
  • Department of Pathophysiology and Transplantation, Università Degli Studi di Milano, Milan, Italy.

ORCID profiles: Maurizio Romagnuolo, Vittoria Cioppa, Angelo Valerio Marzano, Chiara Moltrasio

Cite

APA

Romagnuolo, M., Calabrese, L., D'Onghia, M., Cioppa, V., Rubegni, P., Marzano, A. V., & Moltrasio, C. (2025). The Role of Cutaneous B‐Cells in Hidradenitis Suppurativa: From Preclinical Evidence to Novel Targeted Therapies. Experimental Dermatology, 34(9). https://doi.org/10.1111/exd.70163

Vancouver

Romagnuolo M, Calabrese L, D'Onghia M, Cioppa V, Rubegni P, Marzano AV, et al. The Role of Cutaneous B‐Cells in Hidradenitis Suppurativa: From Preclinical Evidence to Novel Targeted Therapies. Experimental Dermatology. 2025;34(9). doi:10.1111/exd.70163

BibTeX
@article{Romagnuolo2025,
  author = {Romagnuolo, Maurizio and Calabrese, Laura and D'Onghia, Martina and Cioppa, Vittoria and Rubegni, Pietro and Marzano, Angelo Valerio and Moltrasio, Chiara},
  title = {The Role of Cutaneous B‐Cells in Hidradenitis Suppurativa: From Preclinical Evidence to Novel Targeted Therapies},
  journal = {Experimental Dermatology},
  year = {2025},
  volume = {34},
  number = {9},
  doi = {10.1111/exd.70163}
}
Start for free →